MDVLQ — Medavail Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- $0.00m
- -$12.65m
- $43.11m
- 41
- 84
- 12
- 42
Annual cashflow statement for Medavail Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.22 | -4.26 | -26.8 | -43.8 | -47.6 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.357 | 0.382 | 2.32 | 1.92 | 2.7 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.814 | 1.11 | -5.95 | -3 | -7.41 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -3.25 | -2.37 | -28.6 | -42.5 | -47.7 |
| Capital Expenditures | 0 | — | -0.662 | -0.841 | -1.22 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | -0.155 | -2.47 | -1.06 |
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | — | -0.817 | -3.31 | -2.27 |
| Financing Cash Flow Items | -0.108 | — | -5.76 | -0.624 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.34 | 2.42 | 78.6 | 7.93 | 42 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.908 | 0.049 | 49.1 | -37.9 | -7.97 |